Dr Reddy’s Laboratories reported a 14% YoY drop in Q3 net profit to Rs 1,210 crore, even as revenue rose 4% to Rs 8,727 crore. Lower margins and a 12% decline in North America sales weighed on performance, partly offset by strong growth in India, Europe and Emerging Markets.
